Corrigendum to “Design, Synthesis, Biological Evaluation, and In Silico Studies of Quinoxaline Derivatives as Potent p38αMAPK Inhibitors”

IF 3.6 3区医学 Q2 CHEMISTRY, MEDICINAL

Archiv der Pharmazie Pub Date : 2025-10-06 DOI:10.1002/ardp.70120

引用次数: 0

Abstract

Anjali, P. Kamboj, O. Alam, et al., “Design, Synthesis, Biological Evaluation, and In Silico Studies of Quinoxaline Derivatives as Potent p38αMAPK Inhibitors,” Archiv der Pharmazie 357, no. 1 (2024): e2300301. https://doi.org/10.1002/ardp.202300301.

These corrections are reflected in the updated 2D Figure 1 and do not affect the scientific conclusions of the original manuscript. We apologize for the oversight and appreciate the opportunity to rectify these errors.

Abstract Image

查看原文本刊更多论文

“设计、合成、生物学评价和喹啉衍生物作为有效的p38αMAPK抑制剂的硅研究”的更正。

Anjali， P. Kamboj， O. Alam，等，“喹诺啉衍生物作为p38αMAPK抑制剂的设计、合成、生物学评价和硅研究”，中国药理学杂志，357,no。1 (2024): e2300301。https://doi.org/10.1002/ardp.202300301.These修改反映在更新后的2D图1中，不影响原稿的科学结论。我们为疏忽道歉，并感谢有机会纠正这些错误。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Archiv der Pharmazie 医学-化学综合

CiteScore

7.90

自引率

5.90%

发文量

176

审稿时长

3.0 months

期刊介绍： Archiv der Pharmazie - Chemistry in Life Sciences is an international journal devoted to research and development in all fields of pharmaceutical and medicinal chemistry. Emphasis is put on papers combining synthetic organic chemistry, structural biology, molecular modelling, bioorganic chemistry, natural products chemistry, biochemistry or analytical methods with pharmaceutical or medicinal aspects such as biological activity. The focus of this journal is put on original research papers, but other scientifically valuable contributions (e.g. reviews, minireviews, highlights, symposia contributions, discussions, and essays) are also welcome.